Health 20 Jan 2022 Euroz backs Australian pharma Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn A pharmaceutical company specialising in the treatment of common colds and viral diseases will list on the ASX this month, having raised $7 million through an IPO.
